Health Care & Life Sciences » Biotechnology | Chiome Bioscience Inc.

Chiome Bioscience Inc.

Chiome Bioscience Inc.
Stock Exchange Tokyo Stock Exchange
EPS
JPY61.6
Market Cap
JPY7.41 B
Shares Outstanding
32.77 M
Public Float
24.59 M

Profile

Address
Sumitomo Fudosan Nishi-Shinjuku Bldg
Tokyo Tokyo 151
Japan
Employees -
Website http://www.chiome.co.jp
Updated 07/08/2019
Chiome Bioscience, Inc. engages in the manufacture and sale of antibody drugs through the Autonomous Diversifying Library (ADLib) System. Its operations are carried out through Innovative Drug and Innovative Drug Support business segments. The Innovative Drug segment manufactures specific antibodies based on new antigen mechanisms and licenses these out to pharmaceutical industries.

Financials

View All

Shigeru Kobayashi
President & Representative Director
Zaigen Bijodaira
Director & Manager-Corporate Planning